Three-letter DNA “words” can decide whether a yeast cell cranks out a medicine efficiently or sputters along. The words are called codons, and they are the genetic code’s way of spelling out amino ...
Alltrna has raised another $109 million in a series B to fund the Flagship Pioneering biotech's mission to "stop codon disease" with potential benefits for a range of genetic diseases caused by ...
Alltrna is advancing a new class of genetic medicines based on the power of tRNA biology to universally treat Stop Codon Disease, which encompasses thousands of genetic diseases caused by a premature ...